PTPA and ovarian cancer: Furthermore, overexpression of tripartite motif-containing 29 (TRIM29) is closely associated with adverse clinical outcomes in ovarian cancer and promotes the proliferation, migration, and invasion of ovarian cancer cells via the SETBP1/SET/PP2A carcinogenic signal axis (14).